azimilide has been researched along with Cardiac Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharucha, DB; Dorian, P; Kowey, PR; Mahaffey, KW; Robinson, VM | 1 |
| Grönefeld, GC; Hohnloser, SH | 1 |
| Al-Khalidi, HR; Brum, JM; Camm, AJ; Holroyde, MJ; Marcello, SR; Pratt, CM; Schwartz, PJ; Singh, SN | 1 |
| Connolly, SJ; Kerr, CR; Kowey, P; Page, RL; Pritchett, EL; Ruda, MY; Ruzyllo, W; Wilkinson, WE | 1 |
| Connolly, SJ; Marcello, SR; Page, RL; Pritchett, EL; Schnell, DJ; Wilkinson, WE | 1 |
1 review(s) available for azimilide and Cardiac Failure
| Article | Year |
|---|---|
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydantoins; Imidazoles; Imidazolidines; Meta-Analysis as Topic; Piperazines; Placebos; Primary Prevention; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2002 |
3 trial(s) available for azimilide and Cardiac Failure
| Article | Year |
|---|---|
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
Topics: Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Early Termination of Clinical Trials; Electric Countershock; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Humans; Hydantoins; Male; Middle Aged; Odds Ratio; Piperazines; Proportional Hazards Models; Stroke Volume; Tachycardia, Ventricular; Ventricular Fibrillation | 2017 |
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Hydantoins; Hypertension; Imidazoles; Imidazolidines; Male; Middle Aged; Neutropenia; Piperazines; Prevalence; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Coronary Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Tachycardia, Paroxysmal; Treatment Outcome | 2006 |
1 other study(ies) available for azimilide and Cardiac Failure
| Article | Year |
|---|---|
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Myocardial Ischemia; Piperazines; Randomized Controlled Trials as Topic; Recurrence | 2001 |